Max Robotics — Global Service Robot Directory + US Certification

About

Uwe Haverkamp is a leading figure in radiation oncology, specializing in stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS) for thoracic and spinal tumors. His work has significantly advanced the precision and safety of treatment planning for early-stage non-small cell lung cancer (NSCLC) and spinal metastases. Haverkamp’s landmark 2017 planning benchmark study for SBRT of early-stage NSCLC, which has garnered 54 citations, established critical dosimetric guidelines that have been widely adopted in clinical practice. His 2018 study on treatment planning for spinal radiosurgery, with 35 citations, further refined techniques to minimize spinal cord toxicity while maximizing tumor control. These contributions have directly improved patient outcomes by standardizing complex planning processes across institutions. Haverkamp’s research is characterized by rigorous methodology and a focus on translating technical innovations into reproducible clinical protocols. His work remains essential reading for radiation oncologists and medical physicists seeking to optimize SBRT and SRS delivery, cementing his reputation as a key contributor to modern, high-precision cancer therapy.